Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melvin Skip Olson

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Comparative Effectiveness Research|November 28, 2019
Can real-world evidence save pharma US$1 billion per year? A framework for an integrated evidence generation strategyMelvin Skip Olson
Journal of Comparative Effectiveness Research|October 21, 2017
Developing an integrated strategy for evidence generationMelvin Skip Olson
Journal of Comparative Effectiveness Research|April 28, 2022
The triple win - implementation science benefits patients, healthcare systems and industry alikeMelvin Skip Olson, Linda Rootkin
Journal of Comparative Effectiveness Research|July 1, 2024
The value of evidence and its role in driving product strategyMelvin Skip Olson, Gorana Capkun
Clinical Pharmacology and Therapeutics|March 11, 2025
Integrated Evidence Planning for Enhancing Patient Care: Harnessing the Power of Real-World EvidenceGorana Capkun, Melvin Skip Olson
Journal of Comparative Effectiveness Research|August 12, 2025
Are you implementation ready? An alternative patient and healthcare system-centered model for pharmaMelvin Skip Olson, Rita Freitas
Circulation|August 23, 2021
Letter by Olson et al Regarding Article, "Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative"Melvin Skip Olson, Chinmay Deshpande, Kristijan H Kahler
Journal of Comparative Effectiveness Research|June 22, 2021
To replicate or not to replicate? Insights and interpretations from a randomized trial duplication initiativeMelvin Skip Olson, Kristijan H Kahler, Amy E Rudolph
Journal of Comparative Effectiveness Research|September 6, 2024
How pharma can amplify product value with implementation scienceMelvin Skip Olson, Leah L Zullig, Sabina De Geest
Therapeutic Innovation & Regulatory Science|April 23, 2025
Assessing the Value of Integrated Evidence Approaches in Drug DevelopmentJoseph A DiMasi, Melvin Skip Olson, Zachary Smith, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Comparative Effectiveness Research|November 28, 2019
Can real-world evidence save pharma US$1 billion per year? A framework for an integrated evidence generation strategyMelvin Skip Olson
Journal of Comparative Effectiveness Research|October 21, 2017
Developing an integrated strategy for evidence generationMelvin Skip Olson
Journal of Comparative Effectiveness Research|April 28, 2022
The triple win - implementation science benefits patients, healthcare systems and industry alikeMelvin Skip Olson, Linda Rootkin
Journal of Comparative Effectiveness Research|July 1, 2024
The value of evidence and its role in driving product strategyMelvin Skip Olson, Gorana Capkun
Clinical Pharmacology and Therapeutics|March 11, 2025
Integrated Evidence Planning for Enhancing Patient Care: Harnessing the Power of Real-World EvidenceGorana Capkun, Melvin Skip Olson
Journal of Comparative Effectiveness Research|August 12, 2025
Are you implementation ready? An alternative patient and healthcare system-centered model for pharmaMelvin Skip Olson, Rita Freitas
Circulation|August 23, 2021
Letter by Olson et al Regarding Article, "Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative"Melvin Skip Olson, Chinmay Deshpande, Kristijan H Kahler
Journal of Comparative Effectiveness Research|June 22, 2021
To replicate or not to replicate? Insights and interpretations from a randomized trial duplication initiativeMelvin Skip Olson, Kristijan H Kahler, Amy E Rudolph
Journal of Comparative Effectiveness Research|September 6, 2024
How pharma can amplify product value with implementation scienceMelvin Skip Olson, Leah L Zullig, Sabina De Geest
Therapeutic Innovation & Regulatory Science|April 23, 2025
Assessing the Value of Integrated Evidence Approaches in Drug DevelopmentJoseph A DiMasi, Melvin Skip Olson, Zachary Smith, et al.
Pageof 2